Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Elevance Health Inc. (ELV) released a profit for fourth quarter that decreased from last year The company's bottom line totaled $418 ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Centene (CNC) stock and Molina Healthcare (MOH) stock were among notable gainers after a Q4 revenue beat from their Medicaid peer, Elevance Health (ELV). Read more here.

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...

ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.